Pharma industry growth slows down

Update: 15:46 | 01/02/2021

The pharmaceutical industry’s revenues rose by just 3 percent in 2020, down from an average of 11.8 percent in the previous five years.

But it was a notable year for mergers and acquisitions. According to analysts at SSI Securities, the total value of M&A was VND1.68 trillion ($73 million) last year and involved a number of foreign investors.

Pharma industry growth, SSI Securities, foreign investors

SSI analysts estimated the pharmaceutical industry to grow by 15 percent in 2021. 

In May, South Korean conglomerate SK Group, which makes anti-cancer and cardiovascular drugs and mental health medications, paid VND920 billion to acquire a 25 percent stake in Imexpharm Pharmaceutical Joint Stock Company.

In August, Japan’s Aska Pharmaceutical acquired a 24.9 percent stake in Ha Tay Pharmaceutical Joint Stock Company (Hataphar).

In December, German generic drugmaker Stada paid VND400 billion to increase its stake in Pymepharco by 6 percent to nearly 76 percent.

SSI analysts estimated the pharmaceutical industry to grow by 15 percent in 2021 mainly due to a rapidly aging population and rising incomes.

Vietnam eyes 500 hi-tech manufacturers
Vietnam eyes to have 500 manufacturers of hi-tech products and 200 agriculture companies using hi-tech applications as of 2030.
 
FDI down by 62 pct
Foreign direct investment pledges fell by 62.2 percent in January to $2.02 billion, according to the Foreign Investment Agency under the Ministry of Planning and Investment.
 

Source: VnExpress

 
Bình luận mới vừa được thêm vào. Click để xem
Mới nhấtHay nhấtXếp theo: